Biggest News Aggregation in the World
๐Ÿ“ฐ Eligo Bioscience News

Page 5 - Eligo Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Eligo Bioscience. Real-time updates on events, politics, business and more.

Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit

Bacteriophage to the Future: Insights from the 3rd Bacteriophage Therapy Summit Bacteriophages infecting bacteria (illustration) [Christoph Burgstedt/Science Photo Library/Getty Images] The overuse of broad-spectrum antibiotics has led to the development of multi-resistant bacterial strains, rendering antibiotics useless in the treatment of many infectious diseases. As bacteriophages have re-emerged in recent times and the potential of phage or phage-derived products being used in a clinical se...
Bruxelles Capitale Mina Pastagia Jean Paul Pirnay Sailaja Puttagunta Eligo Bioscience Cara Fiore

Global Bacteriophages Therapy Market Growth Factors and Applications by 2028 with Top Key Players: Phage International, Inc, Fixed-Phage Limited, LOCUS BIOSCIENCES, INC., Pherecydes Pharma – KSU

4 Bacteriophages therapy marketย is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 140.76 million and grow at a CAGR of 16.76% in the above-mentioned forecast period. Increasing prevalence of drug-resistant infections drives the bacteriophages therapy market. Bacteriophages Therapy report provides the solid foundation required to accomplish the variety of business challenges that come...
United States Hong Kong United Kingdom Pherecydes Pharma Phagomed Biopharma Gmb Eligo Bioscience

Bacteriophages Therapy Market Size Trends Growth Demand Overall Analysis and Forecast by 2027 || Armata Pharmaceuticals, iNtODEWORLD, Phage International – KSU

This market study on Bacteriophages Therapy Market covers The market study conducted in this report analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors in the industry. Also, it sheds light on the wide-ranging competitive landscape of the global Bacteriophages Therapy market. It defines about the recent innovations, applications and end users of the market.The report first...
United States Hong Kong United Kingdom South Africa Saudi Arabia South Korea

Global Antibiotic Resistance Markets, 2021-2024: Therapeutics by Pathogen and Therapy Type - The Changing Road to New Antibiotics & Technologies

Share this article Share this article ResearchAndMarkets.coms offering. Antimicrobial Resistance is creating new kinds of infections and "superbugs" that are resistant to current antibiotic medicines. New technologies (and new drugs) are under development to capture this growing market. We have identified the 6 Key Large Opportunities in this space and developed market forecasts.The publisher has looked at the technology picture too, giving you, plain language understanding of the different wa...
Johnson Janssen Redhill Biopharma Biofilm Pharma Procarta Biosystems Deinobiotics Deinove Pherecydes Pharma

GSK & Eligo Bioscience targets skin microbiome in €185m acne deal

British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth โ‚ฌ185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne. The agreement terms provide Eligo with an upfront payment along with R&D funding to develop EB005, the Paris-based firmโ€™s discovery program for acne, until preclinical proof of concept. Here, GSK could form a license and collaboration deal with Eligo to further ...
France General Emmanuel Hanon Xavier Duportet Chief Executive Senior Vice President Probiotics And Prebiotics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Skin microbiome investment the fresh focus for European venture capital major Seventure Partners Health for Life Fund

Seventure Partners has been investing in microbiome innovation since the launch of its 2014 Health for Life Fund and will now extend reach of its latest fund due to so much interest (Getty Images) European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin microbiome space. Seventure Partners had been investing in microbiome innovation since the launch of i...
United States Eligo Bioscience Health For Life Fund Life Fund Seventure Partners Vedanta Biosciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science